- Home
- OBIO vs PELI Comparison
OBIO vs PELI Comparison
Compare OBIO & PELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- PELI
- Stock Information
- Founded
- OBIO 2017
- PELI 2024
- Country
- OBIO United States
- PELI United States
- Employees
- OBIO N/A
- PELI N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- PELI
- Sector
- OBIO Health Care
- PELI
- Exchange
- OBIO Nasdaq
- PELI NYSE
- Market Cap
- OBIO 118.8M
- PELI 120.0M
- IPO Year
- OBIO N/A
- PELI 2025
- Fundamental
- Price
- OBIO $3.29
- PELI $10.03
- Analyst Decision
- OBIO Strong Buy
- PELI
- Analyst Count
- OBIO 5
- PELI 0
- Target Price
- OBIO $14.20
- PELI N/A
- AVG Volume (30 Days)
- OBIO 303.1K
- PELI 168.0
- Earning Date
- OBIO 08-11-2025
- PELI 01-01-0001
- Dividend Yield
- OBIO N/A
- PELI N/A
- EPS Growth
- OBIO N/A
- PELI N/A
- EPS
- OBIO N/A
- PELI N/A
- Revenue
- OBIO $2,886,000.00
- PELI N/A
- Revenue This Year
- OBIO $20.47
- PELI N/A
- Revenue Next Year
- OBIO $11.45
- PELI N/A
- P/E Ratio
- OBIO N/A
- PELI N/A
- Revenue Growth
- OBIO 30.23
- PELI N/A
- 52 Week Low
- OBIO $2.37
- PELI $10.01
- 52 Week High
- OBIO $8.30
- PELI $10.43
- Technical
- Relative Strength Index (RSI)
- OBIO 60.31
- PELI N/A
- Support Level
- OBIO $3.05
- PELI N/A
- Resistance Level
- OBIO $3.24
- PELI N/A
- Average True Range (ATR)
- OBIO 0.16
- PELI 0.00
- MACD
- OBIO 0.03
- PELI 0.00
- Stochastic Oscillator
- OBIO 93.75
- PELI 0.00
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About PELI PELICAN ACQUISITION CORPORATION
Pelican Acquisition Corp is a blank check company.